Table 4 Adverse events in intervention and control patients, depending on chemotherapy regimen.

From: The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO)

Chemotherapy regimen

1

2

3

Toxicity

Intervention, N = 21

Control, N = 26

P

Intervention, N = 35

Control, N = 23

P

Intervention, N = 15

Control, N = 22

P

All grades

 Neuropathy

2 (10)

4 (15)

0.439

25 (71)

18 (78)

0.260

1 (7)

1 (45)

0.341

 PPE

11 (52)

15 (58)

0.174

8 (23)

7 (30)

0.708

0

6 (27)

0.030

 Infection

2 (10)

3 (12)

0.824

6 (17)

4 (17)

0.413

1 (7)

4 (18)

0.297

 Fatigue

16 (76)

23 (88)

0.427

34 (97)

21 (91)

0.512

13 (87)

22 (100)

0.207

 Diarrhoea

8 (38)

13 (50)

0.704

16 (46)

14 (61)

0.055

8 (53)

10 (45)

0.427

 Nausea

7 (33)

10 (38)

0.930

21 (60)

12 (52)

0.912

10 (67)

16 (73)

0.187

 Mucostomatitis

4 (19)

12 (46)

0.107

9 (26)

9 (39)

0.349

6 (40)

6 (27)

0.417

 Neutropenia

0

0

NA

4 (11)

4 (17)

0.475

4 (27)

2 (9)

0.217

 Thromboembolism

0

0

NA

2 (5.7)

0

0.506

0

0

NA

Grades 1–2

 Neuropathy

2 (9.5)

2 (7.7)

0.827

28 (80)

14 (61)

0.116

1 (6.7)

1 (4.5)

0.774

 PPE

9 (43)

12 (57)

0.345

7 (20)

7 (30)

0.367

0

6 (27)

0.030

 Infection

2 (9.5)

3 (12)

0.787

2 (5.7)

4 (17)

0.165

6 (40)

4 (18)

0.147

 Fatigue

16 (76)

21 (81)

0.711

31 (89)

20 (87)

0.829

13 (87)

20 (91)

0.675

 Diarrhoea

7 (33)

12 (46)

0.375

13 (37)

12 (52)

0.263

8 (53)

9 (41)

0.458

 Nausea

7 (33)

10 (39)

0.674

19 (54)

11 (48)

0.658

10 (67)

12 (55)

0.478

 Mucostomatitis

4 (19)

12 (46)

0.055

9 (26)

9 (39)

0.284

6 (40)

6 (27)

0.417

 Neutropenia

0

0

NA

3 (8.6)

3 (13)

0.593

3 (20)

2 (9.1)

0.347

 Thromboembolism

0

0

NA

1 (2.9)

0

0.414

0

0

NA

Gade 3+

 Neuropathy

0

2 (7.7)

0.199

1 (2.9)

4 (17)

0.062

0

0

NA

 PPE

2 (9.5)

3 (12)

0.787

1 (2.9)

0

0.414

0

0

NA

 Infection

0

0

NA

6 (17)

2 (8.7)

0.373

2 (20)

2 (9.1)

0.347

 Fatigue

0

2 (7.7)

0.199

3 (8.6)

1 (4.3)

0.531

0

2 (9.1)

0.236

 Diarrhoea

1 (4.8)

1 (3.8)

0.876

3 (8.6)

2 (8.7)

0.989

0

1 (4.5)

0.414

 Nausea

0

0

NA

2 (5.7)

1 (4.3)

0.815

0

4 (18)

0.080

 Mucostomatitis

0

0

NA

0

0

NA

0

0

NA

 Neutropenia

0

0

NA

1 (2.9)

1 (4.3)

0.777

1 (6.7)

0

0.225

 Thromboembolism

0

0

NA

1 (2.9)

0

0.414

0

0

NA

  1. NA not applicable, PPE palmar-plantar erythrodysesthesia.
  2. Note: Data presented as no. (%). Chemotherapy regimen; (1) capecitabine or 5-fluorouracil (+/÷ bevacizumab); (2) capecitabine or 5-fluorouracil + oxaliplatin; (3) capecitabine or 5-fluorouracil + irinotecan.